Director Pittard Christian buys 7,923 shares of HQL at $16.88; first position; stock 6.1% below 52-week high.
Pittard Christian, a director at abrdn Life Sciences Investors (HQL), initiated a new position by purchasing 7,923 shares at $16.88 on 2025-12-16, bringing his total holdings from 0 to 7,923 shares. The purchase price of $16.88 is positioned 1.21 basis points above the current price of $16.67 and $0.87 below the 52-week high of $17.75, placing the entry point near recent high-water marks. The fund's recent price momentum shows a 90-day gain of 18.4% offset by a 30-day decline of 3.4%, suggesting some volatility. This represents a first substantive position for this director and provides a factual data point on the timing and sizing of the initial accumulation decision; no prior trading record context is available to assess pattern.